Search Results - "Yan, Andrew T."

Abnormal Wall Shear Stress Area is Correlated to Coronary Artery Bypass Graft Remodeling 1 Year After Surgery by Tran-Nguyen, Nhien, Yan, Andrew T., Fremes, Stephen, Triverio, Piero, Jimenez-Juan, Laura

“…Coronary artery bypass graft surgery is a common intervention for coronary artery disease; however, it suffers from graft failure, and the underlying…”
Get full text

Chemotherapy-Induced Cardiotoxicity: Detection, Prevention, and Management by Truong, Judy, Yan, Andrew T., MD, Cramarossa, Gemma, BHSc, Chan, Kelvin K.W., MD, MSc

“…Abstract Chemotherapy-induced cardiotoxicity is a major cause of morbidity and mortality in cancer survivors. It might manifest as arrhythmia, hypertension,…”
Get full text

Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction by Hall, Marlous, Bebb, Owen J, Dondo, Tatandashe B, Yan, Andrew T, Goodman, Shaun G, Bueno, Hector, Chew, Derek P, Brieger, David, Batin, Philip D, Farkouh, Michel E, Hemingway, Harry, Timmis, Adam, Fox, Keith A A, Gale, Chris P

“…Abstract Aims To investigate whether improved survival from non-ST-elevation myocardial infarction (NSTEMI), according to GRACE risk score, was associated with…”
Get full text

Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort by Hall, Marlous, Dondo, Tatendashe B, Yan, Andrew T, Mamas, Mamas A, Timmis, Adam D, Deanfield, John E, Jernberg, Tomas, Hemingway, Harry, Fox, Keith A A, Gale, Chris P

“…There is limited knowledge of the scale and impact of multimorbidity for patients who have had an acute myocardial infarction (AMI). Therefore, this study…”
Get full text

Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality by YAN, Andrew T, SHAYNE, Adolphe J, BROWN, Kenneth A, GUPTA, Sandeep N, CHAN, Carmen W, LUU, Tuan M, DI CARLI, Marcelo F, REYNOLDS, H. Glenn, STEVENSON, William G, KWONG, Raymond Y

“…Accurate risk stratification is crucial for effective treatment planning after myocardial infarction (MI). Previous studies suggest that the peri-infarct…”
Get full text

Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes by Poon, Stephanie, MD, MSc, Goodman, Shaun G., MD, MSc, Yan, Raymond T., MD, Bugiardini, Raffaele, MD, Bierman, Arlene S., MD, MSc, Eagle, Kim A., MD, Johnston, Nina, MD, Huynh, Thao, MD, MSc, Grondin, Francois R., MD, Schenck-Gustafsson, Karin, MD, PhD, Yan, Andrew T., MD

“…Background The question of whether gender-related disparities still exist in the treatment and outcomes of patients presenting with acute coronary syndromes…”
Get full text

Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry by Patel, Ashish, Goodman, Shaun G, Yan, Andrew T, Alexander, Karen P, Wong, Camilla L, Cheema, Asim N, Udell, Jacob A, Kaul, Padma, D'Souza, Mario, Hyun, Karice, Adams, Mark, Weaver, James, Chew, Derek P, Brieger, David, Bagai, Akshay

“…Background Little is known about the prognostic implications of frailty, a state of susceptibility to stressors and poor recovery to homeostasis in older…”
Get full text

From Mars to Venus: Gender Differences in the Management and Outcomes of Acute Coronary Syndromes by Tan, Nigel S, Yan, Andrew T

“…Ischemic heart disease remains a leading cause of morbidity and mortality in industrialized nations, and contributes substantially to healthcare expenditure…”
Get more information

Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013 by Gong, Inna Y., Yan, Andrew T., Ko, Dennis T., Earle, Craig C., Cheung, Winson Y., Peacock, Stuart, Hall, Marlous, Gale, Chris P., Chan, Kelvin K. W.

“…BACKGROUND There is a paucity of information about treatment and mortality trends after acute myocardial infarction (AMI) for cancer survivors (CS). METHODS In…”
Get full text

Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis by Harel, Ziv, MD, MSc, Chertow, Glenn M., MD, MS, Shah, Prakesh S., MD, MSc, Harel, Shai, MD, MS, Dorian, Paul, MD, Yan, Andrew T., MD, Saposnik, Gustavo, MD, PhD, Sood, Manish M., MD, MSc, Molnar, Amber O., MD, MSc, Perl, Jeffrey, MS, SM, Wald, Rachel M., MD, MPH, Silver, Sam, MD, MSc, Wald, Ron, MDCM, MPH

“…Abstract Background Patients with atrial fibrillation who receive dialysis are at a high risk of ischemic stroke. The role of warfarin in mitigating this risk…”
Get full text

Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization by Udell, Jacob A., Koh, Maria, Qiu, Feng, Austin, Peter C., Wijeysundera, Harindra C., Bagai, Akshay, Yan, Andrew T., Goodman, Shaun G., Tu, Jack V., Ko, Dennis T.

“…Background Women hospitalized with a non‐ST segment elevation acute coronary syndrome (ACS) have worse clinical outcomes compared with men. An early invasive…”
Get full text

Objective risk assessment vs standard care for acute coronary syndromes-The Australian GRACE Risk tool Implementation Study (AGRIS): a process evaluation by Gullick, Janice, Wu, John, Chew, Derek, Gale, Chris, Yan, Andrew T, Goodman, Shaun G, Waters, Donna, Hyun, Karice, Brieger, David

“…Structured risk-stratification to guide clinician assessment and engagement with evidence-based therapies may reduce care variance and improve patient outcomes…”
Get full text

Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes by Sarak, Bradley, Verma, Subodh, David Mazer, C, Teoh, Hwee, Quan, Adrian, Gilbert, Richard E, Goodman, Shaun G, Bami, Karan, Coelho-Filho, Otávio R, Ahooja, Vineeta, Deva, Djeven P, Garg, Vinay, Gandhi, Sumeet, Connelly, Kim A, Yan, Andrew T

“…Sodium-glucose cotransporter 2 (SGLT2) inhibition reduces cardiovascular events in type 2 diabetes (T2DM) and is associated with a reduction in left…”
Get full text

Empagliflozin and left atrial function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial by Pourafkari, Marina, Connelly, Kim A, Verma, Subodh, Mazer, C David, Teoh, Hwee, Quan, Adrian, Goodman, Shaun G, Rai, Archana, Ng, Ming Yen, Deva, Djeven P, Triverio, Piero, Jiminez-Juan, Laura, Yan, Andrew T, Ge, Yin

“…Sodium-glucose cotransporter-2 (SGLT2) inhibitors have demonstrated reduction in heart failure outcomes in patients with type 2 diabetes mellitus, although the…”
Get full text

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin by Puar, Pankaj, Hibino, Makoto, Mazer, C David, Yan, Andrew T, Pandey, Arjun K, Quan, Adrian, Teoh, Hwee, Hess, David A, Verma, Raj, Connelly, Kim A, Verma, Subodh

“…The cardiovascular (CV) benefits of sodium-glucose transport protein 2 inhibitors have been attributed, in part, to cardiac reverse remodelling. The EMPA-HEART…”
Get full text

Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study by Barthur, Ashita, Brezden-Masley, Christine, Connelly, Kim A, Dhir, Vinita, Chan, Kelvin K W, Haq, Rashida, Kirpalani, Anish, Barfett, Joseph J, Jimenez-Juan, Laura, Karur, Gauri R, Deva, Djeven P, Yan, Andrew T

“…There are limited data on the effects of trastuzumab on the right ventricle (RV). Therefore, we sought to evaluate the temporal changes in right ventricular…”
Get full text

Thiamin deficiency and heart failure: the current knowledge and gaps in literature by Ahmed, Mavra, Azizi-Namini, Parastoo, Yan, Andrew T., Keith, Mary

“…The management of heart failure (HF) represents a significant challenge for both patients as well as the healthcare system in industrialized countries. Thiamin…”
Get full text

Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trial by Barbour, William, Wolff, Erika, Puar, Pankaj, Hibino, Makoto, Bakbak, Ehab, Krishnaraj, Aishwarya, Verma, Raj, Verma, Meena, Quan, Adrian, Yan, Andrew T, Connelly, Kim A, Teoh, Hwee, Mazer, C. David, Verma, Subodh

“…Abstract Background This exploratory sub-analysis of the EMPA-HEART CardioLink-6 trial examined whether the previously reported benefit of the sodium-glucose…”
Get full text

A cluster randomized trial of objective risk assessment versus standard care for acute coronary syndromes: Rationale and design of the Australian GRACE Risk score Intervention Study (AGRIS) by Chew, Derek P., MBBS, MPH, Astley, Carolyn M., RN, DrPH, Luker, Heather, MPH, Alprandi-Costa, Bernadette, RN, Hillis, Graham, MBBS, PhD, Chow, Clara K., MBBS, PhD, Quinn, Steve, PhD, Yan, Andrew T., MD, Gale, Chris P., PhD, Goodman, Shaun, MD, Fox, Keith A.A., MBBS, Brieger, David, MBBS, PhD

“…Background Assessing risk and weighing the potential benefits from evidence-based therapies are essential in the clinical decision making process of optimizing…”
Get full text

The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes by Goodman, Shaun G., MD, MSc, Huang, Wei, MS, Yan, Andrew T., MD, Budaj, Andrzej, MD, PhD, Kennelly, Brian M., MD, PhD, Gore, Joel M., MD, Fox, Keith A.A., MB, ChB, FRCP, Goldberg, Robert J., PhD, Anderson, Frederick A., PhD

“…Background The Global Registry of Acute Coronary Events (GRACE)—a prospective, multinational study of patients hospitalized with acute coronary syndromes…”
Get full text